Literature DB >> 33444298

Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020.

Christopher Prestel, Erica Anderson, Kaitlin Forsberg, Meghan Lyman, Marie A de Perio, David Kuhar, Kendra Edwards, Maria Rivera, Alicia Shugart, Maroya Walters, Nychie Q Dotson.   

Abstract

In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.

Entities:  

Year:  2021        PMID: 33444298     DOI: 10.15585/mmwr.mm7002e3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  51 in total

Review 1.  Emerging and future strategies in the management of recalcitrant Candida auris.

Authors:  Nihal Bandara; Lakshman Samaranayake
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

2.  Commentary: Experimental Mouse Models of Invasive Candidiasis Caused by Candida auris and Other Medically Important Candida Species.

Authors:  Hong Xin
Journal:  J Cell Immunol       Date:  2022

Review 3.  COVID-19 and Fungal Diseases.

Authors:  Kyoung-Ho Oh; Seung-Hoon Lee
Journal:  Antibiotics (Basel)       Date:  2022-06-15

4.  Population genomic analyses reveal evidence for limited recombination in the superbug Candida auris in nature.

Authors:  Yue Wang; Jianping Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-16       Impact factor: 6.155

5.  Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility.

Authors:  Benjamin Williamson; Adam Wilk; Kevin D Guerrero; Timothy D Mikulski; Tony N Elias; Indira Sawh; Geselle Cancino-Prado; Dianne Gardam; Christopher H Heath; Nelesh P Govender; David S Perlin; Milena Kordalewska; Kelley R Healey
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

Review 6.  High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.

Authors:  Kinal Bhatt; Arjola Agolli; Mehrie H Patel; Radhika Garimella; Madhuri Devi; Efrain Garcia; Harshad Amin; Carlos Domingue; Roberto Guerra Del Castillo; Marcos Sanchez-Gonzalez
Journal:  Discoveries (Craiova)       Date:  2021-03-31

Review 7.  Candida auris and other phylogenetically related species - a mini-review of the literature.

Authors:  Cristina Nicoleta Ciurea; Anca Delia Mare; Irina-Bianca Kosovski; Felicia Toma; Camelia Vintilă; Adrian Man
Journal:  Germs       Date:  2021-09-29

8.  Availability and crisis standards of care for personal protective equipment during fall 2020 of the COVID-19 pandemic: A national study by the APIC COVID-19 task force.

Authors:  Terri Rebmann; Rebecca T Alvino; Jill E Holdsworth
Journal:  Am J Infect Control       Date:  2021-03-26       Impact factor: 2.918

9.  Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris Using an Inkjet Printer-Assisted Method.

Authors:  Thea Brennan-Krohn; Liam Friar; Sarah Ditelberg; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

10.  Candida Cell-Surface-Specific Monoclonal Antibodies Protect Mice against Candida auris Invasive Infection.

Authors:  Jonothan Rosario-Colon; Karen Eberle; Abby Adams; Evan Courville; Hong Xin
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.